Status:

COMPLETED

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborating Sponsors:

Open Philanthropy

Conditions:

Sepsis

Septic Shock

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in pa...

Detailed Description

Sepsis and Septic Shock are common and highly morbid clinical conditions without any specific therapy aside from antibiotics. A recent quasi-experimental study (Marik et. al., PMID 27940189) demonstra...

Eligibility Criteria

Inclusion

  • Adult patient (age ≥ 18 years)
  • Suspected (cultures drawn and antibiotic given) or confirmed (via culture results) infection
  • Receiving vasopressor (norepinephrine, phenylephrine, epinephrine, dopamine, angiotensin II or vasopressin)

Exclusion

  • Member of a protected population (pregnant, prisoner)
  • Known kidney stones within the past 1 year (except for asymptomatic, incidentally noted stones on imaging)
  • End stage renal disease (ESRD) requiring dialysis
  • Known Glucose-6-Phosphate Dehydrogenase deficiency
  • Known Hemachromatosis
  • Comfort Measures Only status
  • Anticipated death within 24-hours despite maximal therapy (as determined by the enrolling physician)
  • Receiving supplemental thiamine in a dose greater than that contained in a multivitamin
  • Clinical indication for steroids (e.g. chronic use) as determined by the clinical team providing this drug
  • Clinical indication for thiamine as determined by the clinical team providing this drug
  • Clinical indication for ascorbic acid as determined by the clinical team providing this drug
  • Known allergy to vitamin C, hydrocortisone, or thiamine

Key Trial Info

Start Date :

February 9 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2020

Estimated Enrollment :

205 Patients enrolled

Trial Details

Trial ID

NCT03389555

Start Date

February 9 2018

End Date

February 28 2020

Last Update

February 16 2021

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Mayo Clinic - Arizona

Phoenix, Arizona, United States, 85054

2

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

3

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

4

Mount Auburn Hospital

Cambridge, Massachusetts, United States, 02138